AbCellera Reports Q1 2026 Earnings with Mixed Financial Results

AbCellera (ABCL) reported first-quarter earnings on May 11, 2026. The company generated $8 million in revenue for the quarter compared to $4 million a year ago, primarily from research fees. Despite an increase in R&D expenses and a modest improvement in net loss, AbCellera ended with strong liquidity of approximately $531 million.

By Motley Fool Transcribing · Motley Fool ·

AbCellera Reports Q1 2026 Earnings with Mixed Financial Results

Topics: biotech/pharma finance research and development

Read the full article at Motley Fool

More World news